Subbu Nambi Stock Analyst Profile - Guggenheim Research Coverage - Stocknear

Subbu Nambi

Stock Analyst at Guggenheim

(3.91)
# 2043
Out of 5,493 analysts
46
Total ratings
Success rate
Average return

22 Stocks

Name Action PT Current % Upside Ratings Updated
TEM Tempus AI
Maintains: Strong Buy
80 95
78.48 21.05% 4 Sep 26, 2025
GH Guardant Health
Maintains: Strong Buy
56 67
60.03 11.61% 6 Sep 25, 2025
CAI Caris Life Sciences
Maintains: Strong Buy
32 36
29.19 23.33% 2 Aug 13, 2025
DHR Danaher
Reiterates: Buy
250 250
184.84 35.25% 2 Jul 23, 2025
WGS GeneDx Holdings
Maintains: Strong Buy
88 115
117.21 -1.89% 1 Jun 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
13 10
5.67 76.37% 3 Jun 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
122 114
91.69 24.33% 3 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
50 50
26.91 85.8% 2 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
10 10
9.2 8.7% 1 Apr 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
60 60
53.57 12% 2 Apr 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Apr 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
45 37
33.44 10.65% 3 Apr 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 3 Feb 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
170 200
162.97 22.72% 2 Jan 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Oct 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
4.13 45.28% 1 Jun 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
0.83 622.89% 1 Jun 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Jun 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Jun 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
22.71 10.08% 1 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Dec 14, 2023